Acceso usuarios
Eldar Sultanow, Carsten Brockmann
How to ensure non-manipulated, original pharmaceutical products to be sold to the final consumer is a matter of national interest. In this contribution we are going to present an approach which combines both information technology as well as process reengineering to ensure pharmaceutical correctness and safety of the drugs sold. Firstly, requirements for a model will be determined. Secondly, existing approaches and their pitfalls are presented. Finally, we will introduce a new model for controlling the security of pharmaceutical supply chains.
